Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer

Michael Friedlander; Phyllis Butow; Martin Stockler; Corona Gainford; Julie Martyn; Amit Oza; Heidi S. Donovan; Brigitte Miller; Madeline King

doi:10.1111/IGC.0b013e3181bf7fb8

Article info

7th International Symposium on Advanced Ovarian Cancer

Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer

Authors

Michael Friedlander Prince of Wales Hospital, Sydney, New South Wales, Australia; PubMed articles Google scholar articles
Phyllis Butow Department of Psychology, University of Sydney, New South Wales, Australia, PubMed articles Google scholar articles
Martin Stockler NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia; PubMed articles Google scholar articles
Corona Gainford NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia; PubMed articles Google scholar articles
Julie Martyn NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia; PubMed articles Google scholar articles
Amit Oza Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; PubMed articles Google scholar articles
Heidi S. Donovan School of Nursing, University of Pittsburgh, PA; and PubMed articles Google scholar articles
Brigitte Miller Wake Forest Medical School, Winston Salem, NC. PubMed articles Google scholar articles
Madeline King Department of Psychology, University of Sydney, New South Wales, Australia, PubMed articles Google scholar articles

Address correspondence and reprint requests to Michael Friedlander, MB, ChB, FRACP, Prince of Wales Hospital, Sydney, New South Wales, Australia. E-mail: m.friedlander{at}unsw.edu.au.

Citation

Friedlander M, Butow P, Stockler M, et al

Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer

International Journal of Gynecologic Cancer 2009;19:S44-S48.

Publication history

Received September 2, 2009
First published November 1, 2009.

Online issue publication

March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password